These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. CDKN2A(p16) and HRAS are frequently mutated in vulvar squamous cell carcinoma. Trietsch MD; Spaans VM; ter Haar NT; Osse EM; Peters AA; Gaarenstroom KN; Fleuren GJ Gynecol Oncol; 2014 Oct; 135(1):149-55. PubMed ID: 25072932 [TBL] [Abstract][Full Text] [Related]
5. The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy. Clancy AA; Spaans JN; Weberpals JI Ann Oncol; 2016 Sep; 27(9):1696-705. PubMed ID: 27329249 [TBL] [Abstract][Full Text] [Related]
6. Vulvar Squamous Cell Carcinoma (VSCC) as Two Diseases: HPV Status Identifies Distinct Mutational Profiles Including Oncogenic Fibroblast Growth Factor Receptor 3. Weberpals JI; Lo B; Duciaume MM; Spaans JN; Clancy AA; Dimitroulakos J; Goss GD; Sekhon HS Clin Cancer Res; 2017 Aug; 23(15):4501-4510. PubMed ID: 28377483 [No Abstract] [Full Text] [Related]
7. Genes, pathways and vulvar carcinoma - New insights from next-generation sequencing studies. Zięba S; Chechlińska M; Kowalik A; Kowalewska M Gynecol Oncol; 2020 Aug; 158(2):498-506. PubMed ID: 32522421 [TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic changes in vulvar squamous cell carcinoma and its precursor lesions: a review of the current literature. Trietsch MD; Nooij LS; Gaarenstroom KN; van Poelgeest MI Gynecol Oncol; 2015 Jan; 136(1):143-57. PubMed ID: 25448458 [TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome. Tessier-Cloutier B; Pors J; Thompson E; Ho J; Prentice L; McConechy M; Aguirre-Hernandez R; Miller R; Leung S; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Hoang LN Mod Pathol; 2021 Feb; 34(2):508-518. PubMed ID: 32792599 [TBL] [Abstract][Full Text] [Related]
10. Somatic Mutation Profiling in Premalignant Lesions of Vulvar Squamous Cell Carcinoma. Zięba S; Pouwer AW; Kowalik A; Zalewski K; Rusetska N; Bakuła-Zalewska E; Kopczyński J; Pijnenborg JMA; de Hullu JA; Kowalewska M Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664330 [TBL] [Abstract][Full Text] [Related]
12. Genomic profiles of Japanese patients with vulvar squamous cell carcinoma. Fujii E; Kato MK; Yamaguchi M; Higuchi D; Koyama T; Komatsu M; Hamamoto R; Ishikawa M; Kato T; Kohno T; Shiraishi K; Yoshida H Sci Rep; 2024 Jun; 14(1):13058. PubMed ID: 38844774 [TBL] [Abstract][Full Text] [Related]
13. Performance of the pattern-based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma. Kortekaas KE; Solleveld-Westerink N; Tessier-Cloutier B; Rutten TA; Poelgeest MIE; Gilks CB; Hoang LN; Bosse T Histopathology; 2020 Jul; 77(1):92-99. PubMed ID: 32236967 [TBL] [Abstract][Full Text] [Related]
14. Clonal Relationship Between Lichen Sclerosus, Differentiated Vulvar Intra-epithelial Neoplasia and Non HPV-related Vulvar Squamous Cell Carcinoma. Pouwer AW; VAN DEN Einden LCG; VAN DER Linden M; Hehir-Kwa JY; Yu J; Hendriks KM; Kamping EJ; Eijkelenboom A; Massuger LFAG; Bulten J; VAN Tilborg AAG; DE Hullu JA; Kuiper RP Cancer Genomics Proteomics; 2020; 17(2):151-160. PubMed ID: 32108037 [TBL] [Abstract][Full Text] [Related]
15. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes. Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785 [TBL] [Abstract][Full Text] [Related]
16. Targeted Molecular Sequencing of Recurrent and Multifocal Non-HPV-associated Squamous Cell Carcinoma of the Vulva. Pors J; Tessier-Cloutier B; Thompson E; Almadani N; Ho J; Gilks B; Huntsman D; Hoang L Int J Gynecol Pathol; 2021 Jul; 40(4):391-399. PubMed ID: 33323855 [TBL] [Abstract][Full Text] [Related]
18. Potential targets for tumor-specific imaging of vulvar squamous cell carcinoma: A systematic review of candidate biomarkers. Huisman BW; Burggraaf J; Vahrmeijer AL; Schoones JW; Rissmann RA; Sier CFM; van Poelgeest MIE Gynecol Oncol; 2020 Mar; 156(3):734-743. PubMed ID: 31928804 [TBL] [Abstract][Full Text] [Related]
19. New treatment standards for vulvar cancer 2020. Woelber L; Jaeger A; Prieske K Curr Opin Obstet Gynecol; 2020 Feb; 32(1):9-14. PubMed ID: 31876635 [TBL] [Abstract][Full Text] [Related]
20. p53 Immunohistochemical Patterns in HPV-Independent Squamous Cell Carcinomas of the Vulva and the Associated Skin Lesions: A Study of 779 Cases. Rakislova N; Alemany L; Clavero O; Saco A; Torné A; Del Pino M; Munmany M; Rodrigo-Calvo MT; Guerrero J; Marimon L; Vega N; Quirós B; Lloveras B; Ribera-Cortada I; Alejo M; Pawlita M; Quint W; de Sanjose S; Ordi J; Vvap Study Group Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33138328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]